Clinical trial
The Role of interferOn and Complement in SecondAry thRombotic micrioangiOpathy (ROSARIO)
NCT07705789 is registered in ClinicalTrials.gov with Sofie Dhaese as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Role of interferOn and Complement in SecondAry thRombotic micrioangiOpathy (ROSARIO)
- Lead sponsor
- Sofie Dhaese
- Phase
- Not applicable
- Overall status
- Not yet recruiting
- Start date
- September 1, 2026
- Completion date
- December 31, 2031
- Enrollment
- 40 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.